• 主页
  • 查找结果
  • Leptin and IL-8: two novel cytokines screened out in childhood lead exposure.

Leptin and IL-8: two novel cytokines screened out in childhood lead exposure.

Toxicology letters (2014-04-09)
Yi Yang, Xuezhong Zhang, Yawen Fu, Hui Yang
摘要

Lead is a toxic heavy metal with many recognized adverse health side effects. The central nervous system is the main target of lead toxicity. Although many studies on lead toxicity were conducted, the mechanism of lead toxicity remains uncertain. One possible attribution is the immature blood-brain barrier that causes lead exposure in children. Few studies have investigated the cytokine changes caused by this exposure. Novel cytokines were detected by RayBio(®) Human Cytokine Antibody Array and validated by enzyme-linked immunosorbent assay. Several children were admitted to West China Second University Hospital, after a serious lead pollution event in longchang, Sichuan, China. A total of 4 children with elevated blood lead levels (BLLs) and 4 children with low BLLs were randomly chosen in the discovery set, and 40 children with elevated BLLs and 40 children with low BLLs were included in the validation set. Leptin and interleukin-8 (IL-8) were identified to be significantly different between children with elevated and low BLLs via RayBio(®) Human Cytokine Antibody Array. In the validation set, IL-8 was higher in children with elevated BLLs [median(P25-P75), 117.69(52.31-233.63) pg/mL] than in children with low BLLs [median(P25-P75): 17.70(10.75-26.52) pg/mL] (p=0.000). Leptin was lower in children with elevated BLLs [median(P25-P75): 1658.23(1421.86-2606.55) pg/mL] than in children with low BLLs [median(P25-P75): 4168.68(3246.32-4744.94) pg/mL] (p=0.000). In children with low BLLs, leptin was higher in children with BLLs<3 μg/dL (N=7) [median(P25-P75): 7220.86(4265.72-7555.15) pg/mL] than in children with BLL ≥ 3 μg/dL (N=33) [median(P25-P75): 4103.86(3163.40-4678.34) pg/mL] (p=0.026); IL-8 was significantly different in children with BLL<4 μg/dL (N=13) [median(P25-P75): 12.49(8.25-14.86) pg/mL] than in children with BLL≥4 μg/dL (N=27) [median(P25-P75): 21.98(13.64-33.50) pg/mL] (p=0.013). The results defined specific changes in cytokine expressions to lead exposure, which can be used to explore the mechanism of lead toxicity and monitor lead exposure.

材料
货号
品牌
产品描述

Sigma-Aldrich
铅, powder, −100 mesh, 99.95% trace metals basis
Sigma-Aldrich
铅, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
铅, wire, diam. 1.0 mm, 99.99% trace metals basis
Sigma-Aldrich
铅, shot, 1-3 mm, 99.995% trace metals basis
Sigma-Aldrich
铅, shot, <2 mm, 99.9% trace metals basis
铅, foil, 150x150mm, thickness 0.5mm, as rolled, 99.95%
铅, foil, 50x50mm, thickness 0.25mm, as rolled, 99.95%
铅, foil, 50x50mm, thickness 0.1mm, as rolled, 99.95%
铅, wire reel, 10m, diameter 0.25mm, as drawn, 99.95%
铅, wire reel, 2m, diameter 0.125mm, as drawn, 99.5%
铅, foil, 100x100mm, thickness 3.0mm, as rolled, 99.95%
铅, foil, 100x100mm, thickness 3.0mm, as rolled, 99.99+%
铅, foil, 100x100mm, thickness 6.0mm, as rolled, 99.99+%
铅, foil, 150x150mm, thickness 0.125mm, as rolled, 99.95%
铅, foil, 150x150mm, thickness 0.15mm, as rolled, 99.95%
铅, foil, 150x150mm, thickness 0.1mm, as rolled, 99.95%
铅, foil, 150x150mm, thickness 0.25mm, as rolled, 99.95%
铅, foil, 150x150mm, thickness 0.55mm, as rolled, 99.999%
铅, foil, 150x150mm, thickness 1.0mm, as rolled, 99.5%
铅, foil, 150x150mm, thickness 1.0mm, as rolled, 99.95%
铅, foil, 250x250mm, thickness 3.0mm, as rolled, 99.95%
铅, foil, 25x25mm, thickness 0.125mm, as rolled, 99.95%
铅, foil, 25x25mm, thickness 0.125mm, as rolled, 99.99+%
铅, foil, 25x25mm, thickness 0.15mm, as rolled, 99.95%
铅, foil, 25x25mm, thickness 0.1mm, as rolled, 99.95%
铅, foil, 25x25mm, thickness 0.25mm, as rolled, 99.95%
铅, foil, 25x25mm, thickness 0.25mm, as rolled, 99.99+%
铅, foil, 25x25mm, thickness 0.55mm, as rolled, 99.999%
铅, foil, 25x25mm, thickness 0.5mm, as rolled, 99.95%
铅, foil, 25x25mm, thickness 0.5mm, as rolled, 99.99+%

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。